HiberGene Diagnostics

Aug 102016
Clinical Innovation Conference - 5-6 October 2016

The Clinical Innovation Collaborative, which comprises the organisations listed below, is holding its 3rd conference which aims to build relationships between Northern Ireland clinical researchers and the pharmaceutical industry with a view to increasing collaborative research and adoption of innovation. Using a cross-sector approach with the needs of patients at the centre of the plans, the

Read more ...
Mar 052015
Meningococcal Disease Diagnostic Performance Published in The Lancet Infectious Diseases

A study using the meningococcal disease diagnostic developed at the laboratories in the Royal Victoria Hospital, Belfast, has recently been published in The Lancet Infectious Diseases. The paper concludes that the meningococcal LAMP assay is straightforward enough to use in any hospital with basic laboratory facilities and provides diagnostically accurate and clinically useful results.

Read more ...
Feb 052015

Belfast Health and Social Caree Trust licensee HiberGene Diagnostics Ltd has raised €2m. The company will use this round of funding to support the commercialisation of its first two rapid molecular tests for Meningococcal Meningitis and Group B Streptococcus, which were developed at the Royal Victoria Hospital in Belfast and which it has licenced from Belfast HSC Trust.

Read more ...
Sep 302014
Belfast Trust Licenses Rapid Group B Streptococcus Diagnostic

Belfast Health and Social Care Trust has licensed its rapid molecular diagnostic for Group B streptococcus to HiberGene Diagnostics Ltd. The Group B streptococcus assay is 100% sensitive and 93% specific when compared to direct culture.

Read more ...
Nov 082013

The patent application filed by Belfast Health and Social Care Trust to protect its rapid meningitis diagnostic has been granted in the USA. Granted patent US8465927 – Detection of Neisseria meningitidis by loop mediated isothermal amplification – is licensed exclusively to HiberGene Diagnostics Ltd, a rapid molecular diagnostics company, for its meningococcal diagnostic.

Read more ...
Oct 042011
Novel Rapid Meningitis Diagnostic Test Moves Closer To Market

  Belfast Trust licenses patent to HiberGene Diagnostics HSC Innovations is pleased to announce that Belfast Health and Social Care Trust has licensed its novel rapid meningitis diagnostic test to HiberGene Diagnostics Ltd, a start-up client company of NovaUCD, the Innovation and Technology Transfer Centre, Dublin, Ireland. Novel Rapid Meningitis Diagnostic Test Moves Closer To

Read more ...